Why the study?
Does the point-of-care testing prothrombin time monitor provide accurate INR results compared to certified INR plasma samples in a field setting?
Does the point-of-care testing prothrombin time monitor provide accurate INR results compared to certified INR plasma samples in a field setting?
A significant proportion of point-of-care prothrombin time monitors showed clinically relevant deviations from certified INR values, highlighting the need for routine large-scale quality assessment.
Answers are grounded in this paper and cite their sources.
INR deviations in POC testing may compromise dosing decisions; leaves open lot-to-lot consistency and requires confirmatory studies.
A system for quality assessment (QA) of the CoaguChek (Roche Diagnostics, Mannheim, Germany) point-of-care testing prothrombin time monitor has been developed by the European Concerted Action on Anticoagulation. Hitherto there has not been an adequate rapid method for CoaguChek QA. Sets of 5 certified international normalized ratio (INR) plasma samples were tested on 539 CoaguChek monitors by experienced staff at 9 Netherlands Thrombosis Centers and results compared with certified INR. A 15% or more deviation has been classified as significant deviation. Overall mean and certified INR values were similar, but 20.3% of participants showed a 15% or more deviation from the certified INR on at least 1 of the 5 QA plasma samples. Statistically significant differences in results with different lots of CoaguChek test strips were found. There is need for large scale QA of CoaguChek monitors. The importance of the 5 CoaguChek certified INR QA plasma samples being tested on a single occasion is demonstrated.
No takes yet. Share an insight, caveat, or question.
Meijer et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: